- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-06-0012718

About Ace Cardiopathy Solutions Private Limited
Data last updated:
Ace Cardiopathy Solutions Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 01 December 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2009PTC196486. Its GSTIN is 07AAICA0648R1Z7 (Delhi). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹29.81 Lakh. It is led by directors including Umesh Munjal (Whole-Time Director) and Gaurav Manocha (Whole-Time Director).
Its last annual general meeting (AGM) was held on 18 August 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 551 5th Floor Krishna Apra Business Square Netaji Subhash Place, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹155.55 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹3.78 Cr (net margin 2.4%) and EBITDA of ₹6.21 Cr (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 5% over five years.
The company has about 67 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹39.24 Cr and satisfied charges of ₹59.08 Cr on record. Court records list 13 cases involving the company, including 5 filed by the company and 8 filed against it; 4 cases are pending. The company has 6 deals on record (3 rights issues, 2 secondary share transfers, 1 funding round), with disclosed funding of ₹32 Lakh; the latest was in March 2020. Its 6 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 4 smaller; the largest is Snibe Diagnostic (India) Private Limited with revenue of ₹156.31 Cr.
Ace Cardiopathy Solutions Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0012718). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website acecardiopathy.com.
Company details
Recognitions & Rankings of Ace Cardiopathy Solutions
Contact details
Ace Cardiopathy Solutions Private Limited's registered office is in New Delhi, Delhi. Its website is acecardiopathy.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address551 5th Floor Krishna Apra Business Square Netaji Subhash Place, New Delhi, Delhi, India – 110034
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Ace Cardiopathy Solutions Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ace Cardiopathy Solutions is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ace Cardiopathy Solutions Private Limited, buy the company report.
Financials of Ace Cardiopathy Solutions Private Limited
FY 2026 filings availableAce Cardiopathy Solutions Private Limited reported revenue of ₹155.55 Cr (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.21 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.78 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ace Cardiopathy Solutions Private Limited, buy the company report.
Board of directors of Ace Cardiopathy Solutions Private Limited
Ace Cardiopathy Solutions has 7 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Umesh Munjal | Whole-Time Director | 01 Dec 2009 | 16 Years 11 Months | Current |
| Seema Sharma | Director | 10 Feb 2026 | 0 Years 8 Months | Current |
| Som Suresh Mirpagar Also directs: SVS Lifesciences Private Limited | Director | 10 Feb 2026 | 0 Years 8 Months | Current |
| Gaurav Manocha Also directs: Alchem the Therapeutics LLP, Indinova Mediwises LLP, Ace Cathtech Private Limited and 1 more | Whole-Time Director | 10 Jul 2012 | 14 Years 3 Months | Current |
| Pooja Dimri Also directs: SBC Finmart Limited | Director | 10 Feb 2026 | 0 Years 8 Months | Current |
| Keyur Deepak Gandhi Also directs: Qurovia Lifesciences Private Limited | Director | 10 Feb 2026 | 0 Years 8 Months | Current |
Peer comparison
Ace Cardiopathy Solutions Private Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Snibe Diagnostic (India) Private Limited | ₹156.31 Cr (FY 2025) | 70.0% | Gurgaon, Haryana, India | |||
| Western Healthcare Solutions Private Limited | ₹156.27 Cr (FY 2025) | 22.0% | Kollam, Kerala, India | |||
| Ace Cardiopathy Solutions Private Limitedthis company | ₹155.55 Cr (FY 2025) | ₹3.78 Cr | 2.4% | -12.0% | 67 | New Delhi, Delhi, India |
| Nexus Ventures Private Limited | ₹154.15 Cr (FY 2025) | 436.0% | Mumbai, Maharashtra, India | |||
| Ajitnath Healthcare Private Limited | ₹154.03 Cr (FY 2025) | 42.0% | Mumbai, Maharashtra, India | |||
| Vygon India Private.Limited | ₹147.79 Cr (FY 2025) | 13.0% | New Delhi, Delhi, India | |||
| Science House Medicals Private Limited | ₹146.5 Cr (FY 2023) | 113.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Ace Cardiopathy Solutions Private Limited, buy the company report.
Auditor
Ace Cardiopathy Solutions Private Limited is audited by A A R K & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A A R K & Associates | FY 2024 | 034295N |
Shareholding
The shareholding of Ace Cardiopathy Solutions Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ace Cardiopathy Solutions Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Mar 2026 | 101255756 | Others | ₹30 Cr | Open | |
| 22 Sep 2025 | 101174113 | Others | ₹6.05 Cr | Open | |
| 03 Jun 2025 | 101124374 | Hdfc Bank Limited | ₹16.65 Lakh | Open | |
| 09 Apr 2025 | 101099159 | Hdfc Bank Limited | ₹15.17 Lakh | Open | |
| 28 Mar 2024 | 100900357 | Others | ₹25 Lakh | Open |
To see the full charge records of Ace Cardiopathy Solutions Private Limited, buy the company report.
Total charge records: 18 View all charges
Deals & funding
Ace Cardiopathy Solutions Private Limited has 6 deals on record (3 rights issues, 2 secondary share transfers, 1 funding round), with disclosed funding of ₹32 Lakh; the latest was in March 2020.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2020 | Rights issue | ₹25.2 Lakh | Investors: 2 individuals |
| Mar 2018 | Rights issue | ₹1.25 Cr | Investors: 2 individuals |
| Oct 2014 | Rights issue | ₹50 Lakh | Investors: 2 individuals |
| Jul 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Ace Cardiopathy Solutions Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ace Cardiopathy Solutions Private Limited has 13 court cases on record: 5 filed by Ace Cardiopathy Solutions, 8 filed against it. 4 cases are pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 2 | 0 |
| NCLAT | 6 | 6 | 4 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT New Delhi | Insolvency matter | Filed against the company by Cardiac Care and Allied Healthprivate Limited and 1 other | Disposed |
| NCLAT, NCLAT New Delhi | Insolvency matter | Filed against the company by Dr. Ghanshyam Bhambhani Suspended Managing Director of Cardiac Care and Allied Health Private Limited | Pending |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed against the company by Dr. Ghanshyam Bhambhani Suspended Managing Director of Cardiac Care and Allied Health Private Limited | Pending |
| District court, North, Delhi | Civil suit | Filed against the company by State | Disposed |
| District court, South West, Delhi | Civil suit | Filed against the company by State | Disposed |
To see the full case history of Ace Cardiopathy Solutions Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Ace Cardiopathy Solutions Private Limited was last rated by Crisil on 30 Jun 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 30 Jun 2020 |
To see the full credit ratings and regulatory alerts of Ace Cardiopathy Solutions Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ace Cardiopathy Solutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ace Cardiopathy Solutions Private Limited has a workforce of 67 employees on its EPFO records as of Oct 08, 2025, across 1 active EPFO establishment.
GST
Ace Cardiopathy Solutions has 4 GST registrations: 4 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICA0648R1Z7 | Delhi | Active | 01 Jul 2017 |
| 08AAICA0648R1Z5 | Rajasthan | Active | 01 Jul 2017 |
| 10AAICA0648R1ZK | Bihar | Active | 04 Dec 2020 |
| 06AAICA0648R1Z9 | Haryana | Active | 12 Nov 2022 |
To see the full GST registrations and return filing status of Ace Cardiopathy Solutions Private Limited, buy the company report.
Recent activity
Ace Cardiopathy Solutions Private Limited has 10 board changes on record since 2009: 7 appointments and 3 cessations. The latest: Keyur Deepak Gandhi was appointed as Director on 10 Feb 2026.
31 earlier events are in the company report.
Frequently asked questions
Ace Cardiopathy Solutions is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 01 December 2009 (17+ years old) and is registered under CIN U51909DL2009PTC196486.
Ace Cardiopathy Solutions has 7 current directors:
- Umesh Munjal - Whole-Time Director
- Gaurav Manocha - Whole-Time Director
- Seema Sharma - Director
- Som Suresh Mirpagar - Director
- Pooja Dimri - Director
- Keyur Deepak Gandhi - Director
- Sandip Kumar Dey - Director
The latest financial statements of Ace Cardiopathy Solutions on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 18 August 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Ace Cardiopathy Solutions is 07AAICA0648R1Z7, registered in Delhi. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 08AAICA0648R1Z5 (Rajasthan), 10AAICA0648R1ZK (Bihar), 06AAICA0648R1Z9 (Haryana).
The CIN (Corporate Identification Number) of Ace Cardiopathy Solutions is U51909DL2009PTC196486. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ace Cardiopathy Solutions has 13 court cases on record: 5 filed by the company and 8 filed against it. 4 are pending. Most are in the district courts.
Ace Cardiopathy Solutions was incorporated on 01 December 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
Ace Cardiopathy Solutions has 6 deals on record (3 rights issues, 2 secondary share transfers, 1 funding round), with disclosed funding of ₹32 Lakh; the latest was in March 2020.
The peers of Ace Cardiopathy Solutions by revenue are Snibe Diagnostic (India) Private Limited, Western Healthcare Solutions Private Limited, Nexus Ventures Private Limited, Ajitnath Healthcare Private Limited, Vygon India Private.Limited and 1 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Keyur Deepak Gandhi was appointed as Director on 10 Feb 2026. Pooja Dimri was appointed as Director on 10 Feb 2026. Sandip Kumar Dey was appointed as Director on 10 Feb 2026. Ace Cardiopathy Solutions has 10 board changes on record in total.
Yes, Ace Cardiopathy Solutions is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-06-0012718).

